MX2022015712A - Probiotico para el tratamiento de infertilidad y perdida recurrente de embarazo. - Google Patents

Probiotico para el tratamiento de infertilidad y perdida recurrente de embarazo.

Info

Publication number
MX2022015712A
MX2022015712A MX2022015712A MX2022015712A MX2022015712A MX 2022015712 A MX2022015712 A MX 2022015712A MX 2022015712 A MX2022015712 A MX 2022015712A MX 2022015712 A MX2022015712 A MX 2022015712A MX 2022015712 A MX2022015712 A MX 2022015712A
Authority
MX
Mexico
Prior art keywords
infertility
treatment
pregnancy loss
recurrent pregnancy
probiotic
Prior art date
Application number
MX2022015712A
Other languages
English (en)
Inventor
Gómez Juan Miguel Rodríguez
Álvarez Leónides Fernández
Navarro Irma Castro
Rodríguez Rebeca Arroyo
Rubio Claudio Alba
Original Assignee
Biosearch S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch S A filed Critical Biosearch S A
Publication of MX2022015712A publication Critical patent/MX2022015712A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invención se refiere a una cepa de la especie Lactobacillus salivarius depositada en la Colección Española de Cultivos Tipo (CECT) con el número de acceso 5713 o un mutante de la misma para su uso en el tratamiento y/o prevención de infertilidad o pérdida recurrente del embarazo en un sujeto femenino. Adicionalmente, la invención se refiere a un método in vitro para monitorizar el efecto de un tratamiento para infertilidad o pérdida recurrente de embarazo en un sujeto femenino con una cepa de la especie Lactobacillus salivarius depositada en la CECT con el número de acceso 5713 o un mutante del mismo.
MX2022015712A 2020-06-10 2020-06-10 Probiotico para el tratamiento de infertilidad y perdida recurrente de embarazo. MX2022015712A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2020/070382 WO2021250289A1 (es) 2020-06-10 2020-06-10 Probiótico para el tratamiento de infertilidad y pérdida recurrente de embarazo

Publications (1)

Publication Number Publication Date
MX2022015712A true MX2022015712A (es) 2023-03-17

Family

ID=71661875

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015712A MX2022015712A (es) 2020-06-10 2020-06-10 Probiotico para el tratamiento de infertilidad y perdida recurrente de embarazo.

Country Status (10)

Country Link
US (1) US20230210923A1 (es)
EP (1) EP4166151A1 (es)
JP (1) JP7495530B2 (es)
KR (1) KR20230024973A (es)
CN (1) CN116456996A (es)
AU (1) AU2020453190A1 (es)
BR (1) BR112022025304A2 (es)
CA (1) CA3179833A1 (es)
MX (1) MX2022015712A (es)
WO (1) WO2021250289A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024013376A1 (en) * 2022-07-15 2024-01-18 Chemo Research, S.L. Lactobacillus salivarius strains and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3412766B1 (en) * 2017-06-06 2021-01-27 Casen Recordati, S.L. Lactobacillus salivarius strain, composition comprising the same, and uses thereof
CN109394794A (zh) * 2018-06-29 2019-03-01 广东益可维健康科技有限公司 预防治疗妇科疾病的复合益生菌制剂及制备方法与应用

Also Published As

Publication number Publication date
WO2021250289A1 (es) 2021-12-16
BR112022025304A2 (pt) 2023-02-28
US20230210923A1 (en) 2023-07-06
CN116456996A (zh) 2023-07-18
AU2020453190A1 (en) 2023-02-02
EP4166151A1 (en) 2023-04-19
JP7495530B2 (ja) 2024-06-04
CA3179833A1 (en) 2021-12-16
KR20230024973A (ko) 2023-02-21
JP2023528957A (ja) 2023-07-06

Similar Documents

Publication Publication Date Title
Park et al. A lactic acid bacterium isolated from kimchi ameliorates intestinal inflammation in DSS-induced colitis
MX2008006546A (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
López et al. Distinct Bifidobacterium strains drive different immune responses in vitro
Leite et al. Probiotic potential of selected lactic acid bacteria strains isolated from Brazilian kefir grains
Delgado et al. Subtractive screening for probiotic properties of Lactobacillus species from the human gastrointestinal tract in the search for new probiotics
Mohankumar et al. Characterization and antibacterial activity of bacteriocin producing Lactobacillus isolated from raw cattle milk sample
UA42092C2 (uk) Штам молочнокислих бактерій bifidobacterium breve, штам молочнокислих бактерій bifidobacterium infantis, штам молочнокислих бактерій bifidobacterium longum для покращення кишкової флори, спосіб покращення кишкової флори
MX2022003373A (es) Composiciones a base de cepas bacterianas y su uso como antiinflamatorios.
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
MX2022003374A (es) Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales.
MX2022003372A (es) Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales.
NO306699B1 (no) Tarmkanal-koloniserende lactobasiller, samt fremgangsmåte for isolering og anvendelse derav, samt blanding
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
AR086677A2 (es) Composicion de bacterias de acido lactico y su uso para hacer un suplemento alimentario de higiene o farmaceutica para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias
MX2022003375A (es) Composiciones a base de cepas bacterianas y extractos de bayas y su uso como antinflamatorios.
MX2020013439A (es) Composiciones probioticas y usos de las mismas.
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
ATE432337T1 (de) Probiotische bifidobacterium arten
MX2022007796A (es) Preparacion que comprende cepas probioticas para la degradacion del gluten.
Bansal et al. Isolation and characterization of lactic acid bacteria from fermented foods
MX2022015712A (es) Probiotico para el tratamiento de infertilidad y perdida recurrente de embarazo.
Uugantsetseg et al. Antioxidant activity of probiotic lactic acid bacteria isolated from Mongolian airag
Englerová et al. The study of the probiotic potential of the beneficial bacteria isolated from kefir grains
SG11202000113QA (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof
MX2024006254A (es) Uso de postbioticos en el tratamiento y/o prevencion de los trastornos de ansiedad.